EUROPA UOMO European Prostate Passport Recommendations from Berlin 23.03.2007.

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

Prostate Cancer What a GP Needs to Know
European Guidelines for the HIV Treatment Esteban Martínez Infectious Diseases Unit Hospital Clínic University of Barcelona Barcelona SPAIN.
PROSTATE CANCER da Vinci Robot Surgery Cedric Emery, MD. FACS
British Association of Urological Surgeons Metastatic Prostate Cancer Guidelines.
CA of Prostate:Incidence In a 50 y/o man In a 50 y/o man In autopsy: 40% In autopsy: 40% Clinical: 10% Clinical: 10% Death: 3% Death: 3% Most common non-cutanous.
Bones Cancer The primary bone cancer is a rare type of cancer that affects the human skeleton. Unlike the secondary, originates in the bone and not the.
NEW OPTIONS IN PROSTATE CANCER TREATMENT Presented by Triangle Urology Associates, P.A.
Steven Joniau Filip Ameye
What You Need to Know for Better Bone Health. A quick lesson about bones: Why healthy bones matter The healthier your bones The more active you can be.
Prostate Cancer Int. 洪 毓 謙. Prostate cancer is the Second leading cause of death from cancer in the United States American male, the lifetime risk of:
Controversies in the management of PSA-only recurrent disease Stephen J. Freedland, MD Associate Professor of Urology and Pathology Durham VA Medical Center.
M Ravanbod Medical oncologist Bushehr – 11/91 A 50 y/o white man comes for check up and wants to discuss about prostate cancer. Negative family history.
 These slides were extracted from a larger set of comprising a presentation entitled “Comparing Treatment Results of PROSTATE CANCER” dated 15_01_2013(3).
ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.
Brachytherapy Medical radiation.
Health care Experience of People with the Greatest Health care Needs: How Quebec Compares Results of the 2008 Commonwealth Fund International Health Policy.
Prostate Cancer James B. Benton,M.D.. Prostate Cancer Significant of the clinical problem Early detection/screening Prevention/Management.
Prostate Cancer Case Presentation Shireen Siddiqui.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Silent Voice Survey A survey of prostate cancer patients in Europe OVERVIEW OF RESULTS.
Prostate Cancer Prostate cancer is the most common cancer detected in American men. The lifetime risk of a 50-year-old man for latent CaP is 40%; for.
Dan Spratt, MD Department of Radiation Oncology Neuroendocrine Prostate Cancer: FDG-PET and Targeted Molecular Imaging.
Case Presentation HKC A 78 y/o man obstructive symptoms Flank pain(_) Gross hematuria(-). LUTS(+)
A 74 year old man underwent open prostatectomy due to moderate to severe urinary symptoms unresponsive to medical therapy. Preoperative PSA was 4.1 Postoperatively.
A GENERAL OVERVIEW OF PROSTATE CANCER. PROSTATE CANCER 101 SPONSORED BY THE CALIFORNIA STATE PROSTATE CANCER COALITION AND THE NATIONAL ALLIANCE OF STATE.
Using Radiation in Medicine. There are 3 main uses of radiation in medicine: Treatment Diagnosis Sterilization.
Processing a new patient What are the steps?. What can happen before the patient comes into the office. The new patient is available online at the Parker.
PROSTATE CANCER: RADIATION THERAPY APPROACHES ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT.
Management of Senior Adults with Prostate Cancer Patients’ Perspectives Louis Denis - Europa Uomo Milan,
Prostate Cancer: Treatment choices Prostate Cancer: Treatment choices Winston W Tan MD FACP Winston W Tan MD FACP Senior Consultant Senior Consultant Genitourinary.
Prostate Cancer Screening Risk Management Ben Inch.
Prostate Screening in the New Millennium Dr Pamela Ajayi MD PathCare.
Slainte an Chlar Health Education Day Cancer 20 th Feb 2010.
Prostate Cancer Management: A Guide for Patients and Caregivers
LUTS Audit Gopal Krishana Singh. Method Brownhills – Patients Searched all patient on medical treatment Looked at the notes to identify (recorded) – IPSS.
Leadership Presentation Erin Woodby Nursing 4580 Middle Tennessee State University School of Nursing.
Understanding Prostate Myths
Would you recommend our service to friends and family?
David Spellberg, MD Naples Urological Associates High Intensity Focused Ultrasound Sonablate ® HIFU A Minimally Invasive Way to Treat Prostate Cancer.
Renub Research Global Prostate Cancer Therapeutics Market to 2020 Renub Research Published: November, 2015 Copyright © 2015.
Quality & Sustainability in Cancer Control: A System Performance Spotlight Report To use a hyperlink, right click on it and select ‘Open Hyperlink’, or.
Carcinoma of the prostate. INTRODUCTION Prostate cancer is the most common cancer diagnosed and is the second leading cause of cancer death in men in.
Prostate Cancer Awareness In association with. What is Prostate Cancer?
Within the Cancer Program in MUH doing the best research and providing the best care to our patients. This is the best cancer care hospital.cancer care.
Start the Conversation
2nd Health Education Day Cancer 18th June 2011
Patient Group Meeting Wednesday 22nd March 2017.
A SINGLE MEDICAL DATABASE AND A SINGLE APPOINTMENT APPLICATION
Fig. 1 Frequency distribution of initial palliative treatment modalities used. EBRT, external beam radiotherapy. Initial palliative treatment modality.
Radiation therapy for Early Stage Prostate Cancer
Bladder Cancer and Prostatic Cancer
Prostate cancer นพ.ชัชชัย หอมเกตุ.
PHEN Clinical Trials Rally
Go to
Coordination (benign lesions)
Bones Cancer The primary bone cancer is a rare type of cancer that affects the human skeleton. Unlike the secondary, originates in the bone and not the.
CONVERSATIONS ON PROSTATE CANCER
Here is the graph of a function
Prostate Cancer: Highlights from 2006
Experiences of health care providers in reception centers with a patient-held personal health record for asylum seekers – a multi-sited qualitative study.
Antonio Alcaraz, Pierre Teillac  European Urology Supplements 
Prostate Cancer Update
Guru Sonpavde, MD, Teresa G. Hayes, MD  Mayo Clinic Proceedings 

A case of localized Prostate Cancer Marije Hamaker.
Cervical Cancer Treatment Market is growing continuously and is expected to grow at a CAGR of 6.5% from 2017 to PREPARED BY Market Research Future.
Standardised follow-up
Cervical Cancer Treatment Market is growing continuously and is expected to grow at a CAGR of 6.5% from 2017 to 2023 PREPARED BY Market Research Future.
Presentation transcript:

EUROPA UOMO European Prostate Passport Recommendations from Berlin

Approach In arriving at these recommendations we have reviewed the current passports in use and have taken into account feedback from users

Principles The passport is a Europa Uomo recommended passport – a template The passport should be simple and easy to use Manageable size (e.g. European passport size) It should provide information for the patients to increase their understanding It should have provision for the patients past medical history (prior to Prostate) and to record future prostate development

Requirements of the common European Passport Content Introduction How to use the passport

Requirements of the common European Passport Personal Information My medical history (operations, chronic diseases, treatments) Contact names and numbers (e.g. doctors, hospital, etc)

Requirements of the common European Passport Diagnostic results –PSA Results (listed and by graph) –DRE –Biopsy –Scans –Gleason –Bone density –Others?

Requirements of the common European Passport - Treatments (should there be a description?) –Surgery –Radiotherapy (external beam, brachytherapy) –Hormone Therapy (By type) –Chemotherapy –Other treatments

Requirements of the common European Passport Questions –Frequently asked –My own questions

Requirements of the common European Passport Country information –Support –Internet

Where do we go from here? We suggest that we digitise the resulting template and make it available for the General Assembly.